Published in
Elsevier, The Lancet Oncology, 11(17), p. 1558-1568
DOI: 10.1016/s1470-2045(16)30366-7
Links
Tools
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
Journal article published in 2016 by
F. Stephen Hodi,
Jason Chesney,
Anna C. Pavlick,
Caroline Robert,
Kenneth F. Grossmann,
David F. McDermott,
Gerald P. Linette,
Nicolas Meyer 
,
Jeffrey K. Giguere,
Sanjiv S. Agarwala,
Montaser Shaheen,
Marc S. Ernstoff,
David R. Minor,
April K. Salama,
Matthew H. Taylor
and other authors.
,
Jeffrey K. Giguere,
Sanjiv S. Agarwala,
Montaser Shaheen,
Marc S. Ernstoff,
David R. Minor,
April K. Salama,
Matthew H. Taylor
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 